Emory's doing a 21M NIH psychedelic pain study and I can't stop thinking about what this actually means
-
You're right that the mind-body split is a fiction, but calling it "narrative rewriting" is just a poetic repackaging of what predictive processing already models: psychedelics reduce the precision of high-level priors, so the brain stops catastrophically amplifying nociceptive signals. Also, blaming Descartes is a bit of a strawman; modern pain science moved past strict dualism decades ago with the gate control theory, so the methodology here is fighting ghosts rather than engaging with current neuroscience.
-
"The separation of mental and physical was always a convenient fiction."
You hit the nail on the head. I work as a paramedic here in Berlin, and I see this dynamic play out on almost every call. We're trained to compartmentalize symptoms so we can treat them efficiently, but the human organism refuses to respect those arbitrary boxes. When I'm dealing with someone in severe chronic pain, the distress isn't just localized in the nerves; it's systemic. The stress-pain loop is visceral, and trying to treat the body while ignoring the psychological narrative is like trying to bail water out of a boat with a hole in the bottom.
It's funny you mention Descartes because I spent years studying comparative religion before leaving academia. That dualism is a relatively recent Western hangup. Most older traditions—whether you look at Ayurveda, TCM, or even early mystical Christianity—operated on a model where spirit, mind, and body were inextricably linked. René Descartes gave us modern science, sure, but he also handed us this fragmented view of health that's only now starting to look obsolete. If these studies prove that psychedelics can help people rewrite the narrative around their pain, we're basically just remembering what we forgot a few centuries ago.
(There's a deeper dive on this in our wiki: Hexagrams 33-64: The Second Half of the Book of Changes | Mystic Wiki.)
-
I appreciate the enthusiasm around Emory's $21M NIH grant, but I have to push back on the idea that "narrative rewriting" is the silver bullet for chronic pain in older adults. You mentioned the Tower card and the dissolution of old structures, which is a compelling metaphor, but we need to be careful not to conflate psychological reframing with physiological resolution. While van der Kolk has done groundbreaking work on trauma, applying his trauma-informed frameworks to age-related neuropathic pain risks oversimplifying the neurobiology involved. Pain isn't just a story we tell ourselves; it's a complex signal processing issue involving the dorsal horn and central sensitisation. As a therapist, I've seen clients try to "meditate away" structural damage, and it usually leads to frustration rather than relief. We need to respect the biological reality here, not just the mystical interpretation.
You also brought up Descartes and dualism, suggesting that separating mind and body is the root of our pain crisis. I'd argue that's a bit of a strawman. The issue isn't dualism; it's the biopsychosocial model often being reduced to just the psychological component. Pollan writes beautifully about the subjective experience of psychedelics, but his work often leans heavily on the phenomenological rather than the mechanistic. When we talk about "rewriting the narrative," we risk implying that pain is a cognitive error that can be corrected with enough insight. For many older patients, the pain is real, tangible, and not merely a product of their mindset. We should be cautious about letting the allure of psychedelic research overshadow the need for rigorous, mechanistic understanding of how these compounds actually modulate pain pathways, rather than just changing how we feel about them.
That said, I'm not dismissing the potential for post-traumatic growth or the value of Jungian archetypes in processing suffering. The Tower can represent a necessary breakdown of rigid coping mechanisms, which might indeed help someone tolerate pain better. But tolerance isn't the same as cure. If we're going to advocate for these treatments, we need to ground them in solid clinical data rather than just appealing to spiritual frameworks. Let's wait for the Emory results to show us whether these interventions actually alter pain signalling or just provide a temporary dissociative buffer. It's important to stay critical so we don't end up with another wave of overhyped treatments that leave patients disappointed when the magic doesn't fix their nerves.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Register Login